Tech Company Financing Transactions

eTheRNA Funding Round

eTheRNA closed a $38.7 million Series B funding round on 8/24/2022. Investors included Novalis LifeSciences, EQT Life Sciences and Fund+.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Belgium-based eTheRNA will use the money to expand investment in its integrated mRNA technology platform and further pursue its new initiatives for a partnership-driven business strategy.

Company Information

Company Status
Private & Independent
Mailing Address
Galileilaan 19
Niel, 2845
Email Address
eTheRNA is an mRNA technology platform company with integrated capabilities including mRNA construct design and optimization, coupled with specialized expertise in designing and manufacturing customized lipid nanoparticles (cLNP) formulations tailored for the prevention and treatment of various pathological states, providing end-to-end solutions for next generation mRNA therapeutics.
eTheRNA LinkedIn Company Profile
Social Media
eTheRNA Company Twitter Account
Company News
eTheRNA News
eTheRNA on Facebook
eTheRNA on YouTube

Management Team

Email & Social
Chief Executive Officer
Bernard Sagaert
  Bernard Sagaert LinkedIn Profile  Bernard Sagaert Twitter Account  Bernard Sagaert News  Bernard Sagaert on Facebook
Vice President
Stefaan De Koker
  Stefaan De Koker LinkedIn Profile  Stefaan De Koker Twitter Account  Stefaan De Koker News  Stefaan De Koker on Facebook
VP - Bus. Development
Marina Cools
  Marina Cools LinkedIn Profile  Marina Cools Twitter Account  Marina Cools News  Marina Cools on Facebook
VP - Bus. Development
Michael Mulqueen
  Michael Mulqueen LinkedIn Profile  Michael Mulqueen Twitter Account  Michael Mulqueen News  Michael Mulqueen on Facebook
VP - Bus. Development
Dirk Van Broekhoven
  Dirk Van Broekhoven LinkedIn Profile  Dirk Van Broekhoven Twitter Account  Dirk Van Broekhoven News  Dirk Van Broekhoven on Facebook
VP - Product Management
Phil Challis
  Phil Challis LinkedIn Profile  Phil Challis Twitter Account  Phil Challis News  Phil Challis on Facebook



Browse more venture capital transactions:

Prev: 8/24/2022: Quivr venture capital transaction
Next: 8/24/2022: Levee Medical venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary